WIPF1 and neoplasm: It is also involved in the activation of CRC [62,63] PTEN was identified as a tumor suppressor and therapeutic target for cancer [64] WIPF1 is a candidate prognostic marker for BC, brain cancer, and CRC [65] ErbB4 gene plays a significant role in BC prognostics and therapy [66].